Case File
efta-efta01811227DOJ Data Set 10CorrespondenceEFTA Document EFTA01811227
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01811227
Pages
0
Persons
0
Integrity
No Hash Available
Loading PDF viewer...
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
Jeffrey M Matusowl
1
From:
Jeffrey Epstein
Sent
Tue 4/20/2010 3:26:28 PM
Subject Re: Update
ok on poland
On Tuc, Apr 20, 2010 at 11:17 AM, Jeffrey M Matusow
wrote:
Jeffrey,
India raised rates by 25bps overnight - as expected although less than JPM had been calling for.
Nevertheless INR strengthened by 0.5%.
Gold is back above $1140. We sold puts last week on the dip to $1135.
Most of the positions are in the money as risk appetite is back after the dip on Friday.
Positions that aren't working -
JPM Preferrcds - trading at $24.11
GM - down $1.50 despite news that the company is paying back the gov't sooner than planned
I want to go long Polish Zloty vs. Euro. Poland is the only country in Europe that grew last year. We
expect rates to rise in 4Q 10 and IQ II, while we don't expect any ECB hikes this year. The PLN sold
off on the plane crash. I want to put on a 1 year forward extra. Let me know.
I'm waiting for levels to go short JPY again.
Jeff
Jeffrey M. Matusow
JPMorgan Pnvate Bank 140 West 57th Street. 33rd Roor. New York. NY 10019
Work. 212 622 70531 Fax. 212 310 0108 1 Email.
EFTA_R1_00180881
EFTA01811227
IRS Circular 230 Disclosure.
JPMorgan Chase & Co and its affiliates do not provide tax advice. Accordingly, any discussion of U.S. tax matters contained herein
(including any attachments) is not intended or written to be used. and cannot be used, in connection with the promobon, marketing or
recommendation by anyone unaffiliated with JPMorgan Chase & Co of any of the matters addressed herein or for the purpose of
avoiding U.S. tax-related penalties.
This email is confidential and subject to important disclaimers and conditions including on
offers for the purchase or sale of securities, accuracy and completeness of information,
viruses, confidentiality, legal privilege, and legal entity disclaimers, available at
http://wwwjpmorgan.com/pages/disclosures/email.
**********************************************rn
***AMA**
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments.
EFTA_R1_00180882
EFTA01811228
Technical Artifacts (3)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.